MAPT and early-onset autosomal dominant Alzheimer disease: After the CSF data gave no indication that the typical biomarker constellation of Alzheimer’s disease was present and there was also no association with clinical/genetic data, the hypothesis was pursued that the biomarker changes of tau/amyloid-ß might be an expression of dysfunctional processes in our patients` brains.